when were glp 1 drugs invented Glucagon-like peptide-1 Five Unexpected New Uses for
Description
Nutr & Diabetes
2017;43(Suppl 1):2S202S7
Glucagon-like peptide-1 is secreted from L-cells of the gut into the bloodstream
They found that when people stop these medications after an average of 39 weeks of treatment, they generally regain weight rapidly, and their cardiometabolic markers return to pre-GLP-1 levels by 1.4 years after treatment has been discontinued
This is plausible enough
But perhaps the most important lesson is this: As appetite decreases, nutrition becomes even more important
